InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,562.96
(
-0.45%
)
US TECH 100
19,195.20
(
-0.39%
)
Dow Jones
40,932.34
(
-0.65%
)
Brent Oil
84.54
(
0.07%
)
Bitcoin
63,799.02
(
-0.45%
)
Post# of 252636
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: iandy post# 120713

Sunday, 05/29/2011 12:38:55 PM

Sunday, May 29, 2011 12:38:55 PM

Post# of 252636
Perhaps because ApoE4 genotype prevalence among AD patients in north EU and USA is around 60% and they hope that if they start the anti-Aß therapy early - before the ß-amyloid plaque burden is too heavy, it might improve the patient's state.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up